20 (AIDX) Accumulated Expenses (2024 - 2026)

20 (AIDX) posted Accumulated Expenses of $598335.0 for Q1 2026, down 23.86% on a QoQ basis from $785784.0 in Q4 2025.

20 (AIDX) Accumulated Expenses (2024 - 2026) Analysis & Trends

20's Accumulated Expenses history runs 3 years deep, the most recent figure standing at $598335.0 for Q1 2026.

  • Quarterly Accumulated Expenses changed N/A year-over-year to $598335.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $598335.0 (changed N/A YoY) and the FY2025 annual result came in at $785784.0, up 126.7% from the prior year.
  • Accumulated Expenses was $598335.0 for Q1 2026 at 20, down from $785784.0 in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $785784.0 in Q4 2025 and bottomed at $346622.0 in Q4 2024.
  • A 3-year average of $576913.7 and a median of $598335.0 in 2026 frame the typical range for Accumulated Expenses.
  • Peak annual rise in Accumulated Expenses reached 126.7% in 2025, while the deepest fall reached 126.7% in 2025.
  • 20's Accumulated Expenses stood at $346622.0 in 2024, then surged by 126.7% to $785784.0 in 2025, then slipped by 23.86% to $598335.0 in 2026.
  • Business Quant data shows AIDX's Accumulated Expenses at $598335.0 in Q1 2026, $785784.0 in Q4 2025, and $346622.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn -
10 20 3.91 Mn -313,912.28 62,884.00

Historic Data

Download Data
DateValue
Mar 31, 2026 598,335.00
Dec 31, 2025 785,784.00
Dec 31, 2024 346,622.00